Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
-
Figure 2
Well-differentiated neuroendocrine neoplasms of the stomach: (a) multiple small polypoid tumours in the corpus region of the stomach associated with chronic atrophic gastritis of the oxyntic mucosa (type 1 gastric NET). (b) ECL cell hyperplasia in the oxyntic mucosa with microtumours. (c) ECL cell hyperplasia in patients with MEN1. (d) Type 3 NEN of the stomach with infiltration of muscular wall.
-
Figure 3
Relative ratios of neuroendocrine tumours of the duodenum defined by their hormone expression. Neuroendocrine tumour archives of the Department of Pathology, University of Kiel, 1970 and 2006. Reproduced with kind permission from Springer Science+Media: Virchows Archiv, Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors, volume 451 supplement 1, ppS9–S27, Klöppel et al. (2007).
-
Figure 8
Pancreatic neuroendocrine tumours: (a) tumour with a diameter of 2 cm (insulinoma without metastases), (b) large malignant tumour (>2 cm) in the head of the pancreas (malignant insulinoma with metastases). Reproduced with kind permission from Springer Science+Media: Virchows Archiv, Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors, volume 451 supplement 1, ppS9–S27, Klöppel et al. (2007).
- © 2011 Society for Endocrinology